Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Informatics » Oxford Molecular Execs Consider Sale of Company, GCG’s Devereux Retires

Oxford Molecular Execs Consider Sale of Company, GCG’s Devereux Retires

Mar 09, 2000
Premium

O

XFORD, UK--Executives at Oxford Molecular have acknowledged that they and their advisors, Donaldson Lufkin & Jenrette International, are considering a sale of the company. The company last month announced 1999 losses of £26 million and plans to cut 55 jobs.

James Hiddleston, a company director here, told BioInform that Oxford Molecular’s bioinformatics business has been expanding and that a new strategy calls for concentrating resources on development of drug discovery software.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Vaccine Supply Chain Hacker Warning

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

Illinois Cuts Forensic Testing Backlog

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

Lying Plea

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

Science Studies on Nonalcoholic Fatty Liver Disease Expression Signatures, Ties Between Gut Microbiome and Major Depression

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

What's Popular?

In Informatics

  1. GA4GH Incorporates as a Not-For-Profit Organization in Canada

  2. Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

  3. 2bPrecise Takes Precision Medicine Platform to Otolaryngology Practice as it Continues to Expand

    Premium

  4. Canadian Consortium Launches COVID Cloud to Support Molecular Research

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.